Vijaya Diagnostic Centre Ltd (VIJAYA) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management raised FY27 revenue growth guidance to at least 20%, up from the previous high-teens forecast, after a strong first-half performance.
- The company plans to commission 8 hubs and 14 spokes between H1FY27-Q1FY28 with 155-160 crore capex, signaling accelerated network expansion.
- A definitive agreement to acquire Arya Wellness Center in Guwahati marks the company's strategic entry into the Northeast market.
Performance Overview
- Sustained strong growth momentum with revenue up 26.7% YoY, driven by a 16.5% increase in test volumes.
- Positive response observed in newer geographies, with a meaningful turnaround in Pune and encouraging traction in West Bengal.
- Existing centers demonstrated robust performance, growing at a 20% rate, highlighting strong underlying demand and market share gains.
- Strategic expansion continues with the commissioning of two hub and seven spoke centers in H1 FY27, and plans for further network strengthening.
- Entered the Northeast region through a business transfer agreement to acquire Arya Wellness Center in Guwahati, Assam.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.